Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Northstar Neuroscience completes $113.9mm IPO

Executive Summary

Northstar Neuroscience (developing an implantable stimulation system to help patients recover from stroke) has sold 8.17mm common shares (including the overallotment) at $15 apiece, netting $113.9mm. The company had initially anticipated a smaller offering of 6mm shares at $12-14, which would have brought in only $78mm.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies